日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer

非小细胞肺癌同步及巩固顺铂和多西他赛化疗联合胸部放疗的I期研究

Zhang, T W; Rodrigues, G B; Louie, A V; Palma, D; Dar, A R; Dingle, B; Kocha, W; Sanatani, M; Yaremko, B; Yu, E; Younus, J; Vincent, M D

Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer

卡培他滨减量治疗老年晚期结直肠癌患者的I/II期临床试验

Vincent, M D; Breadner, D; Cripps, M C; Jonker, D J; Klimo, P; Biagi, J J; Lam, W; O'Connell, A; Whiston, F; Stitt, L; Welch, S A

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

开发和验证索拉非尼治疗癌症患者手足皮肤反应预测指标

Dranitsaris, G; Vincent, M D; Yu, J; Huang, L; Fang, F; Lacouture, M E

Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS

目前影响临床实践的生物标志物:EGFR、ALK、MET、KRAS

Vincent, M D; Kuruvilla, M S; Leighl, N B; Kamel-Reid, S

Optimizing the management of advanced non-small-cell lung cancer: a personal view

优化晚期非小细胞肺癌的治疗管理:个人观点

Vincent, M D

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

预防和管理结直肠癌患者化疗引起的腹泻:加拿大化疗引起腹泻工作组的共识声明

Maroun, J A; Anthony, L B; Blais, N; Burkes, R; Dowden, S D; Dranitsaris, G; Samson, B; Shah, A; Thirlwell, M P; Vincent, M D; Wong, R

Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.

反义寡核苷酸诱导胸苷酸合成酶下调,增强 5-FUdR 对 5-FUdR 耐药 HeLa 细胞的细胞毒性

Ferguson P J, DeMoor J M, Vincent M D, Koropatnick J